Clinical Trial Update: Optimal Dose of Extracorporeal Shock Wave Therapy After Botulinum Toxin Type A Injection for Post-stroke Spasticity [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the optimal dose of extracorporeal shock wave therapy after botulinum toxin type A for post-stroke elbow spasticity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-stroke Elbow Spasticity

Drugs mentioned

• Botulinum toxin type A (botulinum toxin type A)
• Extracorporeal Shock Wave Therapy

Snippet

Sponsor: Yonsei University | Conditions: Post-Stroke Elbow Spasticity | Phase 4 | Status: UNKNOWN